Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Wild cherry bark (Prunus serotina) contains cyanogenic glycosides like prunasin and polyphenolic compounds that suppress cough through antispasmodic effects and bronchial sedation. These bioactive compounds inhibit NF-κB and MAPK inflammatory pathways while providing antioxidant protection with measured activity of 54.3 mg TE/g ABTS.
Reported Benefits (Provisional)
Origin & History
Wild Cherry Bark (Prunus serotina) is derived from the bark of the black cherry tree, native to temperate regions of North America, particularly the United States and Canada. Revered in traditional medicine, it is valued for its respiratory-supporting, anti-inflammatory, and digestive-soothing properties, making it a key botanical for holistic wellness.
Research Narrative (Provisional)
Scientific studies, including in vitro and animal models, support Wild Cherry Bark's traditional uses, highlighting its anti-inflammatory, antioxidant, and respiratory-soothing properties. Research indicates its cyanogenic glycosides contribute to cough suppression and bronchial relaxation. Further human clinical trials are warranted to fully elucidate its efficacy and optimal applications.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Phytochemicals/Bioactives: Cyanogenic glycosides (prunasin, amygdalin), Flavonoids, Polyphenols, Tannins, Caffeic acid, Chlorogenic acid, Sesquiterpenes, Coumarins, Essential oils - Vitamins: A, C, K - Minerals: Magnesium, Potassium, Zinc - Macronutrients: Dietary fiber
Reported Mechanism (Provisional)
Wild cherry bark's cyanogenic glycosides, particularly prunasin, provide sedative and antispasmodic effects on bronchial tissues, suppressing cough reflex sensitivity. Flavonoids including sakuranetin and phenolic compounds inhibit inflammatory pathways by downregulating NF-κB translocation, MAPK signaling, iNOS, and COX-2 expression. The polyphenolic compounds demonstrate antioxidant activity by reducing reactive oxygen species and nitric oxide production, with total phenolic content measured at 14.6 mg GAE/g.
Clinical Narrative (Provisional)
Current evidence for wild cherry bark comes primarily from in vitro and animal studies rather than human clinical trials. In vitro antioxidant studies show DPPH activity of 16.8 mg TE/g and anti-inflammatory effects with protein denaturation IC50 of 53.78 mg/mL. Animal safety studies in rats demonstrated non-toxicity at doses up to 5 g/kg over 2 weeks, with analgesic effects comparable to tramadol. Human clinical trials are needed to establish therapeutic efficacy and optimal dosing protocols.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.